DISEASE CANCELLING
Live / Registered — Registered (as of 07 Sept 2021)
What this means for you
Registered since 07 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88982289
- Registration number
- 6480120
- Mark type
- Stylized text
- Filed
- 06 Dec 2019
- Published for opposition
- 10 Nov 2020
- Registered
- 07 Sept 2021
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 042 — Scientific and technological services: drug discovery services provided through a computer software platform used for research and development in the field of drugs; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials via the internet; research and development of new products; medical and scientific research in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; platform as a service (PAAS) featuring computer software platforms using biology and chemistry analytics for determining drug candidates with reduced toxicity; platform as a service (PAAS) featuring computer software platforms for database mining, database analysis, database management and the application of artificial intelligence; consultancy in relation to the development and implementation of software and software based applications
Owner
- Immuneering Corporation, Cambridge, MA, US
- Immuneering Corporation, Cambridge, MA, US
- Immuneering Corporation, Cambridge, MA, US
Prosecution history
- 07 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Aug 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jul 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jun 2021 — USE AMENDMENT FILED
- 07 Jul 2021 — DIVISIONAL PROCESSING COMPLETE
- 23 Jun 2021 — DIVISIONAL REQUEST RECEIVED
- 23 Jun 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 02 Jul 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Jun 2021 — TEAS STATEMENT OF USE RECEIVED
- 05 Jan 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Nov 2020 — PUBLISHED FOR OPPOSITION
- 21 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED